SRPT - Regenxbio raised to Buy at RBC on pivot to Duchenne
2024-03-08 09:23:14 ET
More on Regenxbio
- REGENXBIO Inc. (RGNX) Q4 2023 Earnings Call Transcript
- Regenxbio: Robust Data, Decent Cash, Never Ending Trials, Buying At Dips
- Regenxbio stock jumps 13% on positive data for DMD drug
- Regenxbio Q4 2023 Earnings Preview
- Seeking Alpha’s Quant Rating on Regenxbio